References
- Reinisch W, Staun M, Bhandari S, et al. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis. 2013;7:429–440.
- Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545–1553.
- Ott C, Liebold A, Takses A, et al. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract. 2012;2012:595970; doi: 10.1155/2012/595970. Epub 2012 Jul 30.
- Wiskin AE, Fleming BJ, Wootton SA, et al. Anaemia and iron deficiency in children with inflammatory bowel disease. J Crohns Colitis. 2012;6:687–691.
- Pels LP, Van de Vijver E, Waalkens HJ, et al. Slow hematological recovery in children with IBD-associated anemia in cases of “expectant management”. J Pediatr Gastroenterol Nutr 2010;51:708–713.
- Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. Inflamm Bowel Dis. 2006;12:123–130.
- Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:47–52.
- Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:513–519.
- Auerbach M, Ballard H. Clinical use of intravenous iron: administration, efficacy, and safety. Hematol Am Soc Hematol Educ Program. 2010;2010:338–347.
- Lee TW, Kolber MR, Fedorak RN, et al. iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6:267–275.
- Gisbert JP, Bermejo F, Pajares R, et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of live. Inflamm Bowel Dis. 2009;15:1485–1491.
- Schröder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease – a randomized controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100:2503–2509.
- Erichsen K, Ulvik RJ, Nysaeter G, et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. Scand J Gastroenterol. 2005;40:1058–1065.
- Avni T, Bieber A, Steinmetz T, et al. Treatment of anemia in inflammatory bowel disease-systematic review and meta-analysis. PLoS One. 2013;8:e75540.
- Laass MW, Straub S, Chainey S, et al. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol. 2014;14:184.
- Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal Classification for Inflammatory Bowel Disease: the Paris Classification. Inflamm Bowel Dis. 2011;17:1314–1321.
- Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.
- Turner D, Griffiths AM, Walters TD, et al. Mathematical weighting of the pediatric Crohn’s Disease Activity Index (PCDAI) and comparison with its other short versions. Inflamm Bowel Dis. 2012;18:55–62.
- WHO. Hemoglobin concentrations for the diagnosis of anemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011 (WHO/NMH/NHD/MNM/11.1).
- Ganzoni AM. [Intravenous iron-dextran: therapeutic and experimental possibilities]. Schweiz Med Wochenschr. 1970;100:301–303.
- Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anemia in inflammatory bowel disease. J Crohns Colitis. 2015;9:211–222.
- Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2013;6:61–70.
- Lindgren S, Wikman O, Befrits R, et al. Intravenous iron sucrose is superior to oral sulfate for correcting anemia and restoring iron stores in IBD patients: a randomized controlled, evaluator-blind, multicentre study. Scand J Gastroenterol. 2009;44:838–845.
- Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol 2008;103:1182–1192.
- Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal Classification for Inflammatory Bowel Disease: the Paris Classification. Inflamm Bowel Dis. 2011;17:1314–1321.